Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
Roche Diabetes Care AG, a subsidiary of the global healthcare leader Roche Holding AG, is headquartered in Switzerland (CH) and operates extensively across Europe, North America, and Asia. Founded in 1896, Roche has established itself as a pioneer in the diabetes care industry, focusing on innovative solutions that enhance the management of diabetes.
The company is renowned for its comprehensive portfolio of blood glucose monitoring systems, insulin delivery devices, and digital health solutions. Roche Diabetes Care's unique approach combines advanced technology with user-friendly design, ensuring patients and healthcare professionals can effectively manage diabetes.
With a strong market position, Roche Diabetes Care AG has achieved significant milestones, including the development of the Accu-Chek product line, which is widely recognised for its accuracy and reliability. The company continues to lead in diabetes management, committed to improving patient outcomes through innovation and quality care.
+54 vs industry average
Roche Diabetes Care AG’s score of 86 is higher than 92% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Medical Device Manufacturing has below-average carbon intensity
The Medical Device Manufacturing industry has reduced its overall emissions by 32% since 2018
No reported emissions data is available for Roche Diabetes Care AG yet.
Roche Diabetes Care AG, headquartered in Switzerland (CH), currently does not have specific carbon emissions data available for the most recent year. As a current subsidiary of Roche Holding AG, any climate commitments or emissions data would be inherited from its parent company.
Roche Holding AG has set ambitious climate targets, which may influence Roche Diabetes Care AG's sustainability initiatives. However, specific reduction targets or achievements for Roche Diabetes Care AG are not detailed in the available information.
The company is part of a broader corporate commitment to sustainability, but without specific emissions data or reduction initiatives outlined for Roche Diabetes Care AG, it is challenging to provide a comprehensive overview of its carbon footprint or climate commitments.
For further insights, it is advisable to refer to Roche Holding AG's sustainability reports or climate strategies, as these may provide relevant context and data cascaded to Roche Diabetes Care AG.
No climate goals have been disclosed for Roche Diabetes Care AG yet.
No scope 3 category breakdown has been disclosed yet.


No peer comparison is available for Roche Diabetes Care AG yet.
PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more